Goodwin Procter LLP advised AbSci on the deal. AbSci announced its acquisition of Denovium, Inc. AbSci is a leading synthetic biology company enabling drug discovery and…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
